BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16319128)

  • 1. Distinct expression profile in fumarate-hydratase-deficient uterine fibroids.
    Vanharanta S; Pollard PJ; Lehtonen HJ; Laiho P; Sjöberg J; Leminen A; Aittomäki K; Arola J; Kruhoffer M; Orntoft TF; Tomlinson IP; Kiuru M; Arango D; Aaltonen LA
    Hum Mol Genet; 2006 Jan; 15(1):97-103. PubMed ID: 16319128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
    Tomlinson IP; Alam NA; Rowan AJ; Barclay E; Jaeger EE; Kelsell D; Leigh I; Gorman P; Lamlum H; Rahman S; Roylance RR; Olpin S; Bevan S; Barker K; Hearle N; Houlston RS; Kiuru M; Lehtonen R; Karhu A; Vilkki S; Laiho P; Eklund C; Vierimaa O; Aittomäki K; Hietala M; Sistonen P; Paetau A; Salovaara R; Herva R; Launonen V; Aaltonen LA;
    Nat Genet; 2002 Apr; 30(4):406-10. PubMed ID: 11865300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of SRF-FOS-JUNB pathway in fumarate hydratase deficiency and in uterine leiomyomas.
    Raimundo N; Vanharanta S; Aaltonen LA; Hovatta I; Suomalainen A
    Oncogene; 2009 Mar; 28(9):1261-73. PubMed ID: 19151755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer.
    Alam NA; Olpin S; Leigh IM
    Br J Dermatol; 2005 Jul; 153(1):11-7. PubMed ID: 16029320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumarate hydratase gene mutation in two young patients with sporadic uterine fibroids.
    Kubinova K; Tesarova M; Hansikova H; Vesela K; Kuzel D; Mara M
    J Obstet Gynaecol Res; 2013 Jan; 39(1):410-4. PubMed ID: 22764886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer.
    Alam NA; Olpin S; Rowan A; Kelsell D; Leigh IM; Tomlinson IP; Weaver T
    J Mol Diagn; 2005 Oct; 7(4):437-43. PubMed ID: 16237213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas.
    Barker KT; Spendlove HE; Banu NS; Bridge JA; Fisher C; Shipley J; Garrett M; Manyonda I; Houlston RS
    Cancer Lett; 2006 Apr; 235(1):136-40. PubMed ID: 15949892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No germline FH mutations in familial breast cancer patients.
    Kiuru M; Lehtonen R; Eerola H; Aittomäki K; Blomqvist C; Nevanlinna H; Aaltonen LA; Launonen V
    Eur J Hum Genet; 2005 Apr; 13(4):506-9. PubMed ID: 15523491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors.
    Lehtonen R; Kiuru M; Vanharanta S; Sjöberg J; Aaltonen LM; Aittomäki K; Arola J; Butzow R; Eng C; Husgafvel-Pursiainen K; Isola J; Järvinen H; Koivisto P; Mecklin JP; Peltomäki P; Salovaara R; Wasenius VM; Karhu A; Launonen V; Nupponen NN; Aaltonen LA
    Am J Pathol; 2004 Jan; 164(1):17-22. PubMed ID: 14695314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.
    Ylisaukko-oja SK; Cybulski C; Lehtonen R; Kiuru M; Matyjasik J; Szymañska A; Szymañska-Pasternak J; Dyrskjot L; Butzow R; Orntoft TF; Launonen V; Lubiñski J; Aaltonen LA
    Eur J Hum Genet; 2006 Jul; 14(7):880-3. PubMed ID: 16639410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer.
    Ahvenainen T; Lehtonen HJ; Lehtonen R; Vahteristo P; Aittomäki K; Baynam G; Dommering C; Eng C; Gruber SB; Grönberg H; Harvima R; Herva R; Hietala M; Kujala M; Kääriäinen H; Sunde L; Vierimaa O; Pollard PJ; Tomlinson IP; Björck E; Aaltonen LA; Launonen V
    Cancer Genet Cytogenet; 2008 Jun; 183(2):83-8. PubMed ID: 18503824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer.
    Chan I; Wong T; Martinez-Mir A; Christiano AM; McGrath JA
    Clin Exp Dermatol; 2005 Jan; 30(1):75-8. PubMed ID: 15663510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.
    Kiuru M; Lehtonen R; Arola J; Salovaara R; Järvinen H; Aittomäki K; Sjöberg J; Visakorpi T; Knuutila S; Isola J; Delahunt B; Herva R; Launonen V; Karhu A; Aaltonen LA
    Cancer Res; 2002 Aug; 62(16):4554-7. PubMed ID: 12183404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline fumarate hydratase mutations and evidence for a founder mutation underlying multiple cutaneous and uterine leiomyomata.
    Chuang GS; Martinez-Mir A; Geyer A; Engler DE; Glaser B; Cserhalmi-Friedman PB; Gordon D; Horev L; Lukash B; Herman E; Cid MP; Brenner S; Landau M; Sprecher E; Garcia Muret MP; Christiano AM; Zlotogorski A
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):410-6. PubMed ID: 15761418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
    Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
    Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene.
    Chuang GS; Martinez-Mir A; Engler DE; Gmyrek RF; Zlotogorski A; Christiano AM
    Clin Exp Dermatol; 2006 Jan; 31(1):118-21. PubMed ID: 16309500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening.
    Tolvanen J; Uimari O; Ryynänen M; Aaltonen LA; Vahteristo P
    Hum Reprod; 2012 Jun; 27(6):1865-9. PubMed ID: 22473397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline fumarate hydratase mutations in families with multiple cutaneous and uterine leiomyomata.
    Martinez-Mir A; Glaser B; Chuang GS; Horev L; Waldman A; Engler DE; Gordon D; Spelman LJ; Hatzibougias I; Green J; Christiano AM; Zlotogorski A
    J Invest Dermatol; 2003 Oct; 121(4):741-4. PubMed ID: 14632190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.
    Smit DL; Mensenkamp AR; Badeloe S; Breuning MH; Simon ME; van Spaendonck KY; Aalfs CM; Post JG; Shanley S; Krapels IP; Hoefsloot LH; van Moorselaar RJ; Starink TM; Bayley JP; Frank J; van Steensel MA; Menko FH
    Clin Genet; 2011 Jan; 79(1):49-59. PubMed ID: 20618355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
    Hodge JC; Morton CC
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.